Francesco Stellacci

This paper develops a broad-spectrum antiviral compound that inhibits multiple respiratory viruses in human airway models and in vivo.

This study demonstrates a mesoscale dialysis system that extends protein synthesis in the PURE cell-free system to 12.5 days with a yield of 1.16 mg/mL GFP.

This study develops CD-SA, a β-cyclodextrin-based nanomaterial that acts as a potent broad-spectrum antiviral against influenza A and B viruses, showing higher efficacy than Oseltamivir in ex vivo and in vivo tests.

This study evaluates a combined anti-influenza therapy using single cell RNA sequencing to show its effectiveness in inhibiting viral replication across different epithelial cell types.

This paper introduces gold nanoparticles labeled with 11-mercapto-1-undecanesulfonate to visualize and characterize amyloid polymorphism using cryo-EM, revealing structural differences between in vivo and in vitro amyloid fibrils.